Contact distributor nearby
Need our help ?

-SulfoBiotics- GYY4137

Item # Unit Size
10 mg

For Research Use Only Products

Storage Condition : 0-5
Shipping Condition : ambient temperature
Purity : ≥95.0%
Chemical name: (4-Methoxyphenyl)morpholinylphosphinodithioic acid, morpholine salt
M.W.: 376.47 
CAS#: 106740-09-4

Product Description:

GYY4137 is one of the synthetic hydrogen sulfide donors derived from Lawsson’s reagent. It is water-soluble and releases H2S very slowly by hydrolysis in aqueous solutions. GYY4137 has shown distinct cellular effects such as anti-hypertensive, anti-atherosclerotic and anti-tumor activities in several reports.

        Fig. 1 H2S Releasing Mechanism of GYY4137s



       Fig. 2 H2S Releasing Curve of GYY4137 in PBS

H2S donors:

1) L. Li, M. Whiteman, Y. Y. Guan, K. L. Neo, Y. Cheng, S. W. Lee, Y. Zhao, R. Baskar, C-H. Tan, and P. K. Moore, “Characterization of a Novel, Water-Soluble Hydrogen Sulfide-Releasing Molecule (GYY4137): New Insights Into the Biology of Hydrogen Sulfide”, Circulation, 2008, 117, 2351.
2) M. Whiteman, L. Li, P. Rose, C-H. Tan, D. B. Parkinson, and P. K. Moore, “The Effect of Hydrogen Sulfide Donors of Lipopolysaccharide-Induced Formation of Inflammatory Mediators in Macrophages”, Antioxid. Redox Signal., 2013, 19, 1749.
3) Z. W. Lee, J. Zhou, C-S. Chen, Y. Zhao, C-H. Tan, L. Li, P. K. Moore, and L-W. Deng, “The Slow-Releasing Hydrogen Sulfide Donor, GYY4137, Exhibits Novel Anti-Cancer Effects In Vitro and In Vivo”, PLos One, 2011, 6, e21077.
4) L. Li, B. Fox, J. Keeble, M. Salto-Tellez, P. G. Winyard, M. E. Wood, P. K. Moore, and M. Whiteman, “The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells”, J. Cell. Mol. Med., 2013, 17, 365.
5) Z. Liu, Y. Han, L. Li, G. Meng, X. Li, M. Shirhan, M. T. Peh, L. Xie, S. Zhou, X. Wang, Q. Chen, W. Dai, C-H. Tan, S. Pan, P. K. Moore and Y. Ji, “The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E-/- mice”, Br. J. Pharmacology, 2013, 169, 1795.